Business Wire

AIT Worldwide Logistics Combines Southern California Teams in Newly Constructed, State-of-the-Art Los Angeles Facility

6.1.2022 22:03:00 EET | Business Wire | Press release

Share

Today, global supply chain solutions leader AIT Worldwide Logistics celebrated the grand opening of a new, modern facility in a popular Los Angeles freight forwarding corridor. The location will soon be the new workplace for more than 100 teammates who were formerly based in other Los Angeles-area AIT properties providing logistics expertise for customers in a wide range of industries, including special services for food, high-tech and life sciences shipping.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220106005020/en/

“After months of strategic planning and coordinated teamwork, I’m excited to see our teams move in and make this beautiful new campus come to life,” said AIT’s President and CEO, Vaughn Moore. “To me, this building is a showcase that reflects our continued growth as a company, and one that will go a long way towards enhancing the delivery of world-class service for our customers, both on the West Coast and around the world.”

“Beyond the brick-and-mortar aspects of the facility, the greatest benefit for our customers is that it’s a single point of access to all of AIT’s transportation logistics services and expertise—from the company’s robust life sciences and high tech verticals to customs clearance,” Moore added.

With 24/7 security—including round-the-clock video and in-person monitoring—18 dock doors, a secure yard, pharmaceutical pre-conditioning capabilities, a cage for high-value freight, and thousands of square feet of freezer and refrigerator space, the two-story, 106,000-square-foot warehouse is also strategically located near the 405 and 110 freeways for quick access to the ports of Los Angeles and Long Beach, as well as Los Angeles International Airport.

AIT’s Chief Operating Officer, Keith Tholan, noted that the size of the campus provides flexibility and scale for the increasingly in-demand service of transloading shipping containers.

“Building this new office and warehouse space from the ground up allowed us to design a highly efficient, more eco-friendly facility that best meets our customers' needs,” Tholan said.

He added that the location’s sustainability-focused features include five electric vehicle chargers in the parking lot, electric forklifts, and energy efficient lighting throughout the building.

Bonded and approved by the U.S. Transportation Safety Administration as a certified cargo screening facility, the new office is also fully compliant with the company’s Customs Trade Partnership Against Terrorism membership and certified to export defense cargo in accordance with International Traffic in Arms Regulations. The facility is also Transported Asset Protection Association and ISO 9001:2015 certified.

With plans to grow the location’s teammate population by about 30% in the coming years, Tholan noted that AIT also designed the space to attract top talent, incorporating state-of-the-art audiovisual and security technology, standing desks, a micro market with healthy food options, and other amenities.

This location joins the more than 50 AIT offices across North America—and more than 100 across the globe.

AIT Worldwide Logistics
1820 195th Street
Torrance, CA 90501

About AIT Worldwide Logistics

AIT Worldwide Logistics is a global freight forwarder that helps companies grow by expanding access to markets all over the world where they can sell and/or procure their raw materials, components and finished goods. For more than 40 years, the Chicago-based supply chain solutions leader has relied on a consultative approach to build a global network and trusted partnerships in nearly every industry, including aerospace, automotive, consumer retail, food, government, healthcare, high-tech, industrial and life sciences. Backed by scalable, user-friendly technology, AIT’s flexible business model customizes door-to-door deliveries via sea, air, ground and rail — on time and on budget. With expert teammates staffing more than 100 worldwide locations in Asia, Europe and North America, AIT’s full-service options also include customs clearance, warehouse management and white glove services. Learn more at www.aitworldwide.com.

Our Mission

At AIT, we vigorously seek opportunities to earn our customers’ trust by delivering exceptional worldwide logistics solutions while passionately valuing our co-workers, partners and communities.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Matt Sanders
Public Relations Manager
+1 (630) 766-8300
msanders@aitworldwide.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release

2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr

Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release

Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye